Patent details
301143
Product Name:
Tralokinumab
The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
Ok
Cancel
You have not selected any documents
Ok
Basic Information
Publication number:
301143
Type:
Certificate
SPC Type:
Medical
Basic Patent Number:
EP1942939
Status:
SPC granted but not yet in force
Application number:
301143
Procedural language:
Dutch
First Applicant Residence Country:
United Kingdom (GB)
Marketing Authorization
Marketing Authorization Number:
EU/1/21/1554
Marketing Authorization Type:
EEA
Marketing Authorization Date:
18/06/2021
Marketing Authorization Country:
European Union (EU)
Dates
Filing date:
03/11/2021
First Marketing Authorization date:
18/06/2021
Grant date:
10/02/2022
Activation date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Registration date:
04/11/2021
SPC/SPC Extension Expiration Date:
28/09/2031
Lapsed By Expiration Date:
Withdrawal date:
Revocation Date:
Invalidity Date:
Withdrawal Market Authorization Date:
Refusal Date:
Applicant/holder
From:
03/11/2021
Name:
MEDIMMUNE LIMITED
Address:
Milstein Building Granta Park, CAMBRIDGE CAMBRIDGESHIRE CB21 6GH, United Kingdom (GB)
Agent
Name:
ir. M.F.J.M. Ketelaars c.s.
From:
03/11/2021
Address:
NLO
Postbus 29720, 2502 LS, Den Haag, Netherlands (NL)
To:
Publication
Bulletin
1
Bulletin Heading:
SPC
Journal edition number:
07/22
Publication date:
16/02/2022
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)
2
Bulletin Heading:
SPC
Journal edition number:
45/21
Publication date:
10/11/2021
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)
Annual Fee
Annual Fee(s) Due Date:
30/09/2026
Annual Fee Number:
21
Annual Fee Amount:
1600 Euro
Last Annual Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date
Document type
Document Description
Number of pages
File Type
10/02/2022
Outgoing Correspondence
Decision grant
1
PDF
/2/1/7/9/3/0800739712/docs/301143_9_461809l504a.pdf
10/02/2022
Certificate
Certificate
1
PDF
/2/1/7/9/3/0800739712/docs/301143_10_spcmedcertificate20220210090920396.pdf
28/01/2022
SPC Documents
Annex SPC
1
PDF
/2/1/7/9/3/0800739712/docs/301143_11_supplprotectioncertificate20220128010746088.pdf
28/01/2022
Incoming Correspondence Paper
Accompanying letter incoming document
2
PDF
/2/1/7/9/3/0800739712/docs/301143_12_incomingcorrespondencepaper20220128010853460.pdf
30/12/2021
Outgoing Correspondence
Letter to applicant
1
PDF
/2/1/7/9/3/0800739712/docs/301143_8_445967l173.pdf
05/11/2021
Outgoing Correspondence
Confirmation receipt request
1
PDF
/2/1/7/9/3/0800739712/docs/301143_5_444321l174.pdf
04/11/2021
Application Form
First filed application form
2
PDF
/2/1/7/9/3/0800739712/docs/301143_1_applicationform20211105085847509.pdf
03/11/2021
SPC Documents
Annex SPC
10
PDF
/2/1/7/9/3/0800739712/docs/301143_0_supplprotectioncertificate20211103125234960.pdf
03/11/2021
SPC Documents
Annex SPC
1
PDF
/2/1/7/9/3/0800739712/docs/301143_2_supplprotectioncertificate20211103125310599.pdf
03/11/2021
SPC Documents
Annex SPC
2
PDF
/2/1/7/9/3/0800739712/docs/301143_3_supplprotectioncertificate20211103125708369.pdf
03/11/2021
SPC Documents
Annex SPC
26
PDF
/2/1/7/9/3/0800739712/docs/301143_4_supplprotectioncertificate20211103125708392.pdf
03/11/2021
SPC Documents
Marketing Authorization SPC
3
PDF
/2/1/7/9/3/0800739712/docs/301143_6_supplprotectioncertificate20211103125753272.pdf
03/11/2021
SPC Documents
Summary of the characteristics of the product
18
PDF
/2/1/7/9/3/0800739712/docs/301143_7_supplprotectioncertificate20211103125708339.pdf